Pulmonary Hypertension Clinical Trials in Cincinnati, Ohio

9 studies are recruiting for pulmonary hypertension in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Cincinnati Medical Center, Cincinnati, Ohio

   Locations

   71 in total

   Run by

   United Therapeutics

   See if you can join NCT06388421 on ClinicalTrials.gov

2. Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   USA015, Cincinnati, Ohio

   Locations

   145 in total

   Run by

   Insmed Incorporated

   See if you can join NCT07179380 on ClinicalTrials.gov

3. An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

   Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   University of Cincinnati Health, Cincinnati, Ohio

   Locations

   23 in total

   Run by

   Liquidia Technologies, Inc.

   See if you can join NCT06129240 on ClinicalTrials.gov

4. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

   The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Christ Hospital, Cincinnati, Ohio

   Locations

   68 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT06526195 on ClinicalTrials.gov

5. Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

   A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of …

   Stage

   Not phased

   Ages

   16 and older

   Site

   Children's Hospital Medical Center, Cincinnati, Cincinnati, Ohio

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT07477197 on ClinicalTrials.gov

6. Pulmonary Hypertension Association Registry

   The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

   Stage

   Not phased

   Ages

   0 and older

   Site

   Cincinnati Children's Hospital, Cincinnati, Ohio

   Locations

   52 in total

   Run by

   Pulmonary Hypertension Association, Inc.

   See if you can join NCT04071327 on ClinicalTrials.gov

7. Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

   This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Christ Hospital, Cincinnati, Ohio

   Locations

   12 in total

   Run by

   Aria CV, Inc

   See if you can join NCT04555161 on ClinicalTrials.gov

8. Safety and Efficacy of FETO in CDH Phase III

   Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group

   Stage

   Phase 3

   Ages

   18 to 50

   Site

   Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT07187206 on ClinicalTrials.gov

9. Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

   Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

   Stage

   Not phased

   Ages

   18 to 50

   Site

   Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT02986087 on ClinicalTrials.gov